Ancef and Hypovolaemia - a phase IV clinical study of FDA data

Summary:

Hypovolaemia is reported as a side effect among people who take Ancef (cefazolin sodium), especially for people who are female, 60+ old, also take Celebrex, and have Breast cancer.

The phase IV clinical study analyzes which people have Hypovolaemia when taking Ancef. It is created by eHealthMe based on reports of 3,257 people who have side effects when taking Ancef from the FDA, and is updated regularly.

What is Ancef?

Ancef has active ingredients of cefazolin sodium. eHealthMe is studying from 3,292 Ancef users. Check the latest studies of Ancef.

What is Hypovolaemia?

Hypovolaemia (a decreased volume of circulating blood in the body) is found to be associated with 893 drugs and 837 conditions by eHealthMe. Check the latest studies of Hypovolaemia.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 28, 2026

3,257 people reported to have side effects when taking Ancef.
Among them, 14 people (0.43%) have Hypovolaemia.

Among these 14 people:

What is the gender of people who have Hypovolaemia when taking Ancef? *

female: 85.71 %
male: 14.29 %

What is the age of people who have Hypovolaemia when taking Ancef? *

What are other drugs people take besides Ancef? *

What are other side effects people have besides Hypovolaemia? *

Sepsis (a severe blood infection that can lead to organ failure and death): 9 people, 64.29%
High Blood Pressure: 9 people, 64.29%
Weakness: 8 people, 57.14%
Mental Status Changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation): 8 people, 57.14%
Oedema (fluid collection in tissue): 8 people, 57.14%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 8 people, 57.14%
Anaemia (lack of blood): 8 people, 57.14%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 8 people, 57.14%
Acute Kidney Failure: 8 people, 57.14%
Stress And Anxiety: 7 people, 50.00%

What are the existing conditions these people have? *

Breast Cancer Metastatic: 6 people, 42.86%
Breast Cancer: 6 people, 42.86%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 7.14%
Nausea (feeling of having an urge to vomit): 1 person, 7.14%
Metastases To Bone (cancer spreads to bone): 1 person, 7.14%
Diabetes: 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Ancef and have Hypovolaemia?

- Check whether Hypovolaemia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ancef:

Ancef (3,292 reports)

Hypovolaemia treatments and more:

Hypovolaemia (8,125 reports)

Browse all side effects of Ancef:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hypovolaemia:

Hypovolaemia (893 drugs)

Browse all the conditions that are associated with Hypovolaemia:

Hypovolaemia (837 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on cefazolin sodium (the active ingredients of Ancef) and Ancef (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.